Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-024242
Filing Date
2021-04-01
Accepted
2021-04-01 18:25:31
Documents
1
Period of Report
2021-03-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9559
  Complete submission text file 0001209191-21-024242.txt   11209
Mailing Address C/O MAPLES CORPORATE SERVICES LIMITED UGLAND HOUSE, PO BOX 309 GRAND CAYMAN E9 KY1-1104
Business Address C/O MAPLES CORPORATE SERVICES LIMITED UGLAND HOUSE, PO BOX 309 GRAND CAYMAN E9 KY1-1104 86 21 61632579
Quan Venture Fund II, L.P. (Reporting) CIK: 0001750370 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40288 | Film No.: 21799789

Mailing Address 991C LOMAS SANTA FE #436 SOLANA BEACH CA 92121
Business Address 991C LOMAS SANTA FE #436 SOLANA BEACH CA 92121 858-293-4900
Design Therapeutics, Inc. (Issuer) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations